- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06933121
Empowering Healthy Lifestyle Behaviour Through Personalised Intervention Portfolios to Prevent and Control Obesity in Children - UEV Pilot Study (UEVCh_HW8)
Study Overview
Status
Intervention / Treatment
Detailed Description
At present, numbers of persons with overweight and obesity continue to grow in most countries worldwide. Children and young adults are at risk for different reasons: in the case of children, dietary habits and lifestyle is starting to be developed and if, at this phase, children do not acquire healthy habits, it will be probable that they will have a higher potential to develop obesity and the associated co-morbidities. It is at this stage that food preferences develop. Moreover, children obesity is increasing and it is known that an obese or pre-obese children will have a higher propensity to be an obese adult. For young adults, the risks and concerns are different. Is in this period of life that most people starts an independent life, and consequently decide their food and lifestyle choices, with an increase in irregularity of meals and unhealthy food choices, together with changes in physical activity habits and social or individual pressures. It is essential to give them tools that will allow them to make healthy choices and to have healthy habits, since they will be the future adult population that will raise and inspire the next generation. As solutions to combat the trend toward increasing overweight and obesity are much in need, the present study aims to intervene with the developed healthy lifestyle recommender solution to address various factors known to constitute a risk for developing obesity, including socio-demographic aspects, psychological/behavioural ones, physical activity, dietary patterns, among other. Such a multi-dimensional portfolio approach is believed to be very much needed for the prevention of obesity and co-morbidities, and the personalization of the solution, as well as the nudging/gamification aspects will strive to ensure a high long-term adherence to the developed solution.
The primary objective of the study is to determine whether the developed healthy-lifestyle recommender solution can be successfully applied to the target population (children and their parents), and whether they adhere to using it frequently during the duration of the study.
This will be assessed by adherence time to the lifestyle recommender solution and questionnaires addressing the user-friendliness and limitation or problems encountered. Secondly, the investigators will study whether the assessment of endpoints required for the ensuing long-term study can be well assessed within the study and if despite the limited time of the intervention duration, the intervention will be able to improve some markers related to the risk of obesity and associated co-morbidities.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elsa Lamy, PhD
- Phone Number: +351266780800
- Email: ecsl@uevora.pt
Study Contact Backup
- Name: Maria Perez-Jimenez, PhD
- Phone Number: +351266780800
- Email: maria.jimenez@uevora.pt
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children (age 5-12 y) and, at least, one of their parents
- To reside in Portugal (for logistic reasons)
- To be overweight (BMI percentile > 85%)
- Both boys and girls
Exclusion Criteria:
- To have manifest chronic diseases (e.g. cancer)
- To be already in energy restriction or following a specific diet (on their own or advised by their physician)
- To have eating behaviour pathologies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital intervention group
Group of individuals that will have access to the digital tool and that will be followed for their used and efficacy.
|
The intervention is the developed eHealth solution, i.e. the healthy lifestyle recommender system. It is based on a previously developed meal recommender system, but will be much extended, resulting in a multilevel portfolio intervention regarding:
The detailed nature of the interventions will first be developed during co-creation and then targeted to the participating individual. Moreover, particular attention will be given, since this needs to be a eHealth solution easy to be used by children. The intervention will include collecting urine and saliva samples, as well as measuring anthropometrics and collecting data (persona |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to digital tool
Time Frame: At the end of the study, after 3-month intervention.
|
Adherence time to the lifestyle recommender solution and questionnaires addressing the user-friendliness and limitation or problems encountered.
This will be quantified according to the scale of the questionnaires.
|
At the end of the study, after 3-month intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in BMI
Time Frame: 3-months
|
we will study whether the assessment of endpoints required for the ensuing long-term study can be well assessed within the study and if despite the limited time of the intervention duration, the intervention will be able to improve some markers related to the risk of obesity and associated co-morbidities.
Toward this end, change of BMI, relatively to the beginning of the intervention will be assessed.
|
3-months
|
|
Salivary biomarkers of stress
Time Frame: 3-months
|
The investigators will study how the intervention will be able to change salivary cortisol and alpha-amylase concentrations.
|
3-months
|
|
Salivary biomarkers of physiology and metabolism
Time Frame: 3-months
|
The levels of different salivary molecules will be measured in the periods before and after intervention, namely: salivary glucose and insulin, salivary C-reactive protein - CRP concentrations.
|
3-months
|
|
Dietary habits
Time Frame: At the beginning of the study
|
The dietary habits of children, at the beginning of the study, will be determined through validated Food Frequency Questionnaires, which will allow to quantify the average amount of each food type consumed per day, as well as the amounts of macro- and micronutrients consumed per day.
|
At the beginning of the study
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UEVHeightW8Children
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity and Obesity-related Medical Conditions
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Amasya UniversityCompletedObesity and Obesity-related Medical ConditionsTurkey
-
Ryazan State Medical UniversityActive, not recruitingObesity and Obesity-related Medical ConditionsRussian Federation
-
Merck Sharp & Dohme LLCCompletedObesity and Obesity-related Medical Conditions
-
Tanta UniversityNot yet recruiting
-
University of Roma La SapienzaCompletedObesity and Obesity-related Medical ConditionsItaly
-
Yuan HeNot yet recruitingObesity and Obesity-related Medical Conditions
-
Medical University of GdanskRecruitingObesity and Obesity-related Medical ConditionsPoland
-
Chinese University of Hong KongRecruitingObesity and Obesity-related Medical ConditionsHong Kong
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingObesity and Obesity-related Medical ConditionsSpain
Clinical Trials on Digital twin for personalized recommendations
-
Galilee CBRUnknown
-
University of ÉvoraNot yet recruiting
-
Hamilton Health Sciences CorporationSouthlake Regional Health Centre; Federal Economic Development Agency for Southern... and other collaboratorsCompletedHealth Behavior | Cardiovascular Risk Factor | Genetic InformationCanada
-
Ukraine Association of BiobankActive, not recruitingImplantation, EmbryoAustria
-
Astrolab bioEPS COMFAMACompletedMicrobiome | Obesity & Overweight | GutColombia
-
Mansoura UniversityEnrolling by invitationSkeletal Class III MalocclusionEgypt
-
Hospital General de MexicoUnknown
-
Poznan University of Life SciencesCompletedDiet Habit | Taste Disorders | Healthy LifestylePoland
-
Sun Yat-sen UniversityCompletedGlaucoma | Diabetic Retinopathy | Cataract | Conjunctivitis | KeratitisChina
-
G. d'Annunzio UniversityCompletedTwin Vaginal Delivery SkillsItaly